5/18
Health Sciences
By the Numbers: Penn Vet’s agricultural impact
In addition to excellence in teaching and clinical care for companion animals, Penn Vet makes indispensable contributions to the state’s agriculture sector.
Penn Medicine sets a worldwide record with 100 kidney paired donation transplants in a year
The Penn Transplant Institute coordinates with the National Kidney Register to help pair the more than 90,000 patients on the waitlist with a deceased donor.
Research shows how stress activates neurons that disrupt sleep
New research from Penn Medicine shows suppressing these neurons may be a promising target for therapies to treat stress-related sleep disorders, like insomnia and PTSD.
First in-human clinical trial of CAR T cell therapy with new binding mechanism shows promising early responses
The therapy tested in a Phase 1 clinical trial might drastically change the way the T cells work, potentially allowing the new CAR T cell product to work where other products have failed.
One in six patients with opioid use disorder leaving the hospital before completing treatment
A new Penn Medicine analysis shows that discharges too early for patients with opioid use disorder increased over 50% between 2016 and 2020.
Inclusive, ambitious research to meet the needs of a changing planet
Collaborative research communities supported by the Environmental Innovations Initiative are addressing issues related to climate action, stewardship of nature, and societal resilience.
Three takeaways on respiratory illness in dogs
Deborah Silverstein of the School of Veterinary Medicine advises dog owners to stay calm but take certain precautions.
The evolution of adaptive immunity in cold-blooded vertebrates
New research from Penn Vet sheds light on the immune system’s evolution in cold-blooded species, with the potential to inform human medicine.
Climate, public health crises, and fertility
Letícia Marteleto, a social demographer new to Penn, does research at the intersection of fertility, Zika, COVID-19, climate conditions, urbanicity, and inequality.
Could a single shot heal heart disease?
Experts at Penn Medicine are researching novel treatments for heart disease, including CRISPR gene editing technology, CAR T technology, and mRNA injections.
In the News
What’s going on with tranq?
Jeanmarie Perron of the Perelman School of Medicine says that the appearance and progression of skin ulcers and tissue loss on xylazine users is different than with other intravenous drugs.
FULL STORY →
It’s time to end the Medicare-Medicaid merry-go-round
In an opinion essay, Rachel M. Werner of the Leonard Davis Institute, Wharton School, and Perelman School of Medicine says that Medicare and Medicaid fail to integrate coverage and coordinate care across their two plans.
FULL STORY →
Inside Penn’s transfer center
Penn Medicine’s transfer command center gets patients from affiliated hospitals and hospitals outside Philadelphia to specialized care that can save lives, with comments from CEO Kevin Mahoney.
FULL STORY →
The quest for treatments to keep weight off after Ozempic
Researchers at Penn are conducting a co-authored study of the brains, fat and muscle cells, and eating patterns of people trying to maintain new body sizes.
FULL STORY →
Operating rooms are major sources of greenhouse gasses. Penn is eliminating a form of anesthesia that hangs in the air for more than a decade after use
Penn Medicine is phasing out the anesthesia desflurane at four of its six hospitals to eliminate harmful greenhouse gases, with remarks from Greg Evans.
FULL STORY →